Medsafe has given a New Zealand psychiatrist approval to prescribe medicinal psilocybin for treating treatment-resistant depression.

General practitioners (GPs) and nurse practitioners will be able to start medical treatment for adults with ADHD, following decisions by Medsafe and Pharmac.

The Director for Radiation Safety (the Director) intends to review the Code of Practice for Irradiating Apparatus: ORS C10 2020 (ORS C10 2020). The review will be conducted in accordance with section ...

Under section 53 of the Residential Care and Disability Support Services Act 2018, the Director-General of Health has determined the maximum contribution that applies in each region for long-term aged ...

This rest home has been audited against the Health and Disability Services Standards.During the last audit, the auditors identified some areas for improvement. Issues from their last audit are listed ...

The consultation on safety measures for the use of puberty blockers in young people with gender-related health needs closed on 20 January 2025. We will now consider submissions.BackgroundThe ...

The Government is reviewing health workforce regulation to improve New Zealanders’ timely, quality access to healthcare. We have an opportunity to put patients at the centre, modernise and streamline ...

The 2014 report from the Royal Society of New Zealand (RSNZ) and the 2021 report from the Office of the Prime Minister’s Chief Science Advisor (OPMCSA) on the risks and benefits of community water ...

Our climate is changing. These changes are affecting what we value most in our lives, including our health and wellbeing. This first Health National Adaptation Plan (HNAP) is an important step towards ...